During the past decade, Gifu University Hospital conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 16 clinical trials were completed, i.e. on average, 34% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 13 clinical trials were completed. i.e. 41.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gifu University Hospital" #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Pfizer" with 7 trials sponsored, "Amgen" with 4 trials sponsored, "Takeda" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gifu University Hospital" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator and "Tokyo Medical and Dental University" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Gifu University Hospital" are "Gastric Cancer" (6 trials), "Ulcerative Colitis" (6 trials), "Colorectal Cancer" (3 trials), "Gastroesophageal Junction Adenocarcinoma" (3 trials) and "Primary Immunodeficiency Diseases (PID)" (3 trials). Many other conditions were trialed in "Gifu University Hospital" in a lesser frequency.

Most popular intervention types in "Gifu University Hospital" are "Drug" (53 trials), "Biological" (6 trials), "Procedure" (4 trials), "Other" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Etrasimod" (5 trials), "Paclitaxel" (4 trials), "Baricitinib" (2 trials) and "Bemarituzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gifu University Hospital" are 58 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Gifu University Hospital". undefined are not yet recruiting, 16 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Gifu University Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Gifu University Hospital, 3 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".